Ppd testing in patients starting infliximab for treatment of inflammatory bowel disease

被引：0
|
作者：
Minor, Melissa
Ghimire, Sanjay
Singh, Surya
机构：
[1] Brigham & Womens Hosp, Boston, MA 02115 USA
[2] D2Hawkeye Inc, Waltham, MA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2008年 / 103卷
关键词：
D O I：
10.14309/00000434-200809001-01042
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1042
引用
收藏
页码：S408 / S408
页数：1
相关论文
共 50 条
  • [1] The Usefulness of PPD Testing in Inflammatory Bowel Disease Patients Before Infliximab Therapy
    Uthman, Imad
    Sharara, Alaa
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004, 2 (09) : XXII - XXII
  • [2] Risk factors predict positive PPD skin test in inflammatory bowel disease patients starting infliximab
    Weinberg, AM
    Aberra, FN
    Su, CY
    McGregor, J
    Lichtenstein, GR
    GASTROENTEROLOGY, 2003, 124 (04) : A197 - A197
  • [3] Safety of infliximab treatment in pediatric patients with inflammatory bowel disease
    Scarbrough, M
    Calabro, C
    Carpenter, E
    Bendorf, K
    Friesen, CA
    Roberts, CC
    Daniel, JF
    Hodge, C
    GASTROENTEROLOGY, 2003, 124 (04) : A519 - A519
  • [4] Safety of infliximab treatment in pediatric patients with inflammatory bowel disease
    Friesen, CA
    Calabro, C
    Christenson, K
    Carpenter, E
    Welchert, E
    Daniel, JF
    Haslag, S
    Roberts, CC
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2004, 39 (03): : 265 - 269
  • [5] Treatment of inflammatory bowel disease with Infliximab. Experience in 25 patients
    Simian, Daniela
    Isabel Quijada, Maria
    Lubascher, Jaime
    Acuna, Raul
    Quera, Rodrigo
    REVISTA MEDICA DE CHILE, 2013, 141 (09) : 1158 - 1165
  • [6] Infliximab pharmacokinetics in inflammatory Bowel disease patients
    Ternant, David
    Aubourg, Alexandre
    Magdelaine-Beuzelin, Charlotte
    Degenne, Danielle
    Watier, Herve
    Picon, Laurence
    Paintaud, Gilles
    THERAPEUTIC DRUG MONITORING, 2008, 30 (04) : 523 - 529
  • [7] High Incidence of Anergy in Inflammatory Bowel Disease Patients Limits the Usefulness of PPD Screening Before Infliximab Therapy
    Mow, William S.
    Abreu-Martin, Maria T.
    Papadakis, Konstantinos A.
    Pitchon, Howard E.
    Targan, Stephan R.
    Vasiliauskas, Eric A.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004, 2 (04) : 309 - 313
  • [8] Infliximab trough levels are decreasing overtime in patients with inflammatory bowel disease on maintenance treatment with infliximab
    Orfanoudaki, E.
    Gazouli, M.
    Foteinogiannopoulou, K.
    Theodouraki, E.
    Legaki, E.
    Koutroubakis, I.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S330 - S331
  • [9] Personalized infliximab treatment of adolescents with inflammatory bowel disease
    Carlsen, K.
    Jakobsen, C.
    Hansen, L.
    Paerregaard, A.
    Munkholm, P.
    Wewer, V.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S408 - S408
  • [10] Minimizing infliximab toxicity in the treatment of inflammatory bowel disease
    Orlando, A.
    Mocciaro, F.
    Civitavecchia, G.
    Scimeca, D.
    Cottone, M.
    DIGESTIVE AND LIVER DISEASE, 2008, 40 : S236 - S246
12345